End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.16 USD | -3.76% | -5.29% | -15.27% |
05-30 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
05-30 | Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- TLSI Stock
- Revisions TriSalus Life Sciences, Inc.